(Q34547847)

2 August 2017

1 reference

title

Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder (English)

1 reference

2 August 2017

Ellen W Freeman

1

1 reference

2 August 2017

1 January 2004

1 reference

2 August 2017

1 reference

2 August 2017

18

1 reference

2 August 2017

7

1 reference

2 August 2017

453-468

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418070-00004

2 August 2017

0 references

cites work

Clinical significance of premenstrual dysphoric changes

1 reference

12 December 2020

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

1 reference

12 December 2020

Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study.

1 reference

12 December 2020

The pathophysiologic background for current treatments of premenstrual syndromes

1 reference

12 December 2020

Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review

1 reference

12 December 2020

A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome

1 reference

12 December 2020

Severity of premenstrual symptoms in a health maintenance organization population

1 reference

12 December 2020

Use of sertraline, paroxetine and fluvoxamine by nursing women

1 reference

12 December 2020

Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial

1 reference

12 December 2020

Long-term fluoxetine treatment of late luteal phase dysphoric disorder.

1 reference

12 December 2020

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

1 reference

12 December 2020

Fluoxetine treatment of severe premenstrual syndrome

1 reference

12 December 2020

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

1 reference

12 December 2020

Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study

1 reference

12 December 2020

Fluvoxamine in the treatment of menstrually related mood disorders.

1 reference

12 December 2020

Antidepressants during pregnancy and lactation: defining exposure and treatment issues

1 reference

12 December 2020

Allopregnanolone in women with premenstrual syndrome.

1 reference

12 December 2020

The premenstrual syndrome. Effects of "medical ovariectomy"

1 reference

12 December 2020

Allopregnanolone concentrations and premenstrual syndrome.

1 reference

12 December 2020

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome

1 reference

12 December 2020

Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors

1 reference

12 December 2020

Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder

1 reference

12 December 2020

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

1 reference

12 December 2020

Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.

1 reference

12 December 2020

Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial

1 reference

12 December 2020

The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study

1 reference

12 December 2020

Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and nonprescribed drugs in women with late luteal phase dysphoric disorder

1 reference

12 December 2020

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

1 reference

12 December 2020

Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial

1 reference

12 December 2020

Serotonin levels and platelet uptake during premenstrual tension

1 reference

12 December 2020

Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes

1 reference

12 December 2020

Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.

1 reference

12 December 2020

Predictors of response to sertraline treatment of severe premenstrual syndromes.

1 reference

12 December 2020

A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.

1 reference

12 December 2020

Treatment of premenstrual dysphoria with alprazolam. A controlled study.

1 reference

12 December 2020

The epidemiology of perimenstrual psychological symptoms.

1 reference

12 December 2020

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Fluvoxamine for premenstrual dysphoric disorder: a pilot study.

1 reference

12 December 2020

Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study

1 reference

12 December 2020

Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales

1 reference

12 December 2020

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

1 reference

12 December 2020

Non-antidepressant treatment of premenstrual syndrome.

1 reference

12 December 2020

Prior benzodiazepine exposure and benzodiazepine treatment outcome

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual syndrome

1 reference

12 December 2020

Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant

1 reference

12 December 2020

Family history of alcoholism in women with generalized anxiety disorder who have premenstrual syndrome: patient reports of premenstrual alcohol consumption and symptoms of anxiety

1 reference

12 December 2020

A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.

1 reference

12 December 2020

Sexual side effects of antidepressants

1 reference

12 December 2020

Compliance to antidepressant drug therapy for treatment of premenstrual syndrome

1 reference

12 December 2020

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

12 December 2020

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

1 reference

12 December 2020

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

12 December 2020

A follow-up study of premenstrual syndrome

1 reference

12 December 2020

Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics

1 reference

12 December 2020

Analysis of seizure dispersion during menstrual cycle in women with epilepsy

1 reference

12 December 2020

Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

12 December 2020

Buserelin in premenstrual syndrome

1 reference

12 December 2020

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries

1 reference

12 December 2020

Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria

1 reference

12 December 2020

Allopregnanolone levels and symptom improvement in severe premenstrual syndrome

1 reference

12 December 2020

Subchronic administration of fluoxetine impairs estrous behavior in intact female rats.

1 reference

12 December 2020

Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria

1 reference

12 December 2020

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

1 reference

12 December 2020

Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women

1 reference

12 December 2020

Fluoxetine in the treatment of late luteal phase dysphoric disorder

1 reference

12 December 2020

Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder

1 reference

12 December 2020

Prevalence of sexual dysfunction among newer antidepressants.

1 reference

12 December 2020

d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression.

1 reference

12 December 2020

Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo

1 reference

12 December 2020

Hormone-related headache

1 reference

12 December 2020

Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder

1 reference

12 December 2020

Nefazodone in the treatment of premenstrual syndrome: a preliminary study

1 reference

12 December 2020

Venlafaxine in the treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual dysphoria

1 reference

12 December 2020

Changes in premenstrual symptoms in women with schizophrenia: a prospective study

1 reference

12 December 2020

A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome

1 reference

12 December 2020

Effects of metergoline on symptoms in women with premenstrual dysphoric disorder

1 reference

12 December 2020

[Premenstrual dysphoric disorder: long-term treatment with fluoxetine and discontinuation]

1 reference

12 December 2020

Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen

1 reference

12 December 2020

Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk

1 reference

12 December 2020

Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle

1 reference

12 December 2020

Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.

1 reference

12 December 2020

Acute tryptophan depletion aggravates premenstrual syndrome

1 reference

12 December 2020

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Paroxetine as a treatment for premenstrual dysphoric disorder

1 reference

12 December 2020

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

1 reference

12 December 2020

Is 5HT1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study

1 reference

12 December 2020

Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo

1 reference

12 December 2020

The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability?

1 reference

12 December 2020

Fluoxetine's spectrum of action in premenstrual syndrome.

1 reference

12 December 2020

Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor

1 reference

12 December 2020

Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one.

1 reference

12 December 2020

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

1 reference

12 December 2020

The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications

1 reference

12 December 2020

Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome

1 reference

12 December 2020

Buspirone in treatment of premenstrual syndrome

1 reference

12 December 2020

Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review

1 reference

12 December 2020

Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls.

1 reference

12 December 2020

Premenstrual symptoms in women with premenstrual asthma

1 reference

12 December 2020

Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Whole-blood serotonin in premenstrual syndrome

1 reference

12 December 2020

10.2165/00023210-200418070-00004

Identifiers

DOI

1 reference

PubMed ID

15139800

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

15139800